The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Fareston     2-[4-[(Z)-4-chloro-1,2- diphenyl-but-1...

Synonyms: SureCN4564, S1776_Selleck, HY-B0005, CCRIS 6719, CHEMBL1200675, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of TOREMIFENE CITRATE


High impact information on TOREMIFENE CITRATE


Chemical compound and disease context of TOREMIFENE CITRATE


Biological context of TOREMIFENE CITRATE


Anatomical context of TOREMIFENE CITRATE


Associations of TOREMIFENE CITRATE with other chemical compounds




Analytical, diagnostic and therapeutic context of TOREMIFENE CITRATE


  1. Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. Wärri, A.M., Huovinen, R.L., Laine, A.M., Martikainen, P.M., Härkönen, P.L. J. Natl. Cancer Inst. (1993) [Pubmed]
  2. Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth. O'Regan, R.M., Cisneros, A., England, G.M., MacGregor, J.I., Muenzner, H.D., Assikis, V.J., Bilimoria, M.M., Piette, M., Dragan, Y.P., Pitot, H.C., Chatterton, R., Jordan, V.C. J. Natl. Cancer Inst. (1998) [Pubmed]
  3. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model. Raghow, S., Hooshdaran, M.Z., Katiyar, S., Steiner, M.S. Cancer Res. (2002) [Pubmed]
  4. Anti-estrogens induce apoptosis of multiple myeloma cells. Treon, S.P., Teoh, G., Urashima, M., Ogata, A., Chauhan, D., Webb, I.J., Anderson, K.C. Blood (1998) [Pubmed]
  5. Treatment-related osteoporosis in men with prostate cancer. Smith, M.R. Clin. Cancer Res. (2006) [Pubmed]
  6. Pharmacokinetics of selective estrogen receptor modulators. Morello, K.C., Wurz, G.T., DeGregorio, M.W. Clinical pharmacokinetics. (2003) [Pubmed]
  7. Effects of transforming growth factor-beta1 and tumour necrosis factor-alpha on cultured fibroblasts from skin fibroma as modulated by toremifene. Lilli, C., Marinucci, L., Bellocchio, S., Ribatti, D., Balducci, C., Baroni, T., Cagini, L., Giustozzi, G., Locci, P. Int. J. Cancer (2002) [Pubmed]
  8. Tamoxifen and toremifene in breast cancer: comparison of safety and efficacy. Buzdar, A.U., Hortobagyi, G.N. J. Clin. Oncol. (1998) [Pubmed]
  9. Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats. Hard, G.C., Iatropoulos, M.J., Jordan, K., Radi, L., Kaltenberg, O.P., Imondi, A.R., Williams, G.M. Cancer Res. (1993) [Pubmed]
  10. Pharmacokinetics of the novel antiestrogenic agent toremifene in subjects with altered liver and kidney function. Anttila, M., Laakso, S., Nyländen, P., Sotaniemi, E.A. Clin. Pharmacol. Ther. (1995) [Pubmed]
  11. Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin. Kivistö, K.T., Villikka, K., Nyman, L., Anttila, M., Neuvonen, P.J. Clin. Pharmacol. Ther. (1998) [Pubmed]
  12. Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus. Li, D., Dragan, Y., Jordan, V.C., Wang, M., Pitot, H.C. Cancer Res. (1997) [Pubmed]
  13. Lack of evidence for tamoxifen- and toremifene-DNA adducts in lymphocytes of treated patients. Bartsch, H., Phillips, D.H., Nair, J., Hewer, A., Meyberg-Solomeyer, G., Grischke, E.M. Carcinogenesis (2000) [Pubmed]
  14. Clastogenic and aneugenic effects of tamoxifen and some of its analogues in hepatocytes from dosed rats and in human lymphoblastoid cells transfected with human P450 cDNAs (MCL-5 cells). Styles, J.A., Davies, A., Davies, R., White, I.N., Smith, L.L. Carcinogenesis (1997) [Pubmed]
  15. The antiestrogen toremifene protects against alcoholic liver injury in female rats. Järveläinen, H.A., Lukkari, T.A., Heinaro, S., Sippel, H., Lindros, K.O. J. Hepatol. (2001) [Pubmed]
  16. Enhancement of Adriamycin cytotoxicity in a multidrug resistant Chinese hamster ovary (CHO) subline, CHO-Adrr, by toremifene and its modulation by alpha 1 acid glycoprotein. Chatterjee, M., Harris, A.L. Eur. J. Cancer (1990) [Pubmed]
  17. Toremifene and its metabolites enhance doxorubicin accumulation in estrogen receptor negative multidrug resistant human breast cancer cells. Wiebe, V., Koester, S., Lindberg, M., Emshoff, V., Baker, J., Wurz, G., DeGregorio, M. Investigational new drugs. (1992) [Pubmed]
  18. Effects of toremifene on neonatal rat uterine growth and differentiation. Medlock, K.L., Branham, W.S., Sheehan, D.M. Biol. Reprod. (1997) [Pubmed]
  19. Prospective evaluation of estrogen receptor-beta in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients. Cappelletti, V., Celio, L., Bajetta, E., Allevi, A., Longarini, R., Miodini, P., Villa, R., Fabbri, A., Mariani, L., Giovanazzi, R., Galante, E., Greco, M., Grazia Daidone, M. Endocr. Relat. Cancer (2004) [Pubmed]
  20. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Ruohola, J.K., Valve, E.M., Karkkainen, M.J., Joukov, V., Alitalo, K., Härkönen, P.L. Mol. Cell. Endocrinol. (1999) [Pubmed]
  21. Drug resistance in chemotherapy for breast cancer. Saeki, T., Tsuruo, T., Sato, W., Nishikawsa, K. Cancer Chemother. Pharmacol. (2005) [Pubmed]
  22. Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines. Mubashar, M., Harrington, K.J., Chaudhary, K.S., Lalani, e.l.-.N., Stamp, G.W., Peters, A.M. Acta oncologica (Stockholm, Sweden) (2004) [Pubmed]
  23. Hepatocellular neoplasms after intrahepatic transplantation of ovarian fragments into ovariectomized rats. Dombrowski, F., Flaschka, C., Klotz, L., von Netzer, B., Schulz, C., Lehnert, H., Evert, M. Hepatology (2006) [Pubmed]
  24. Comparison of the effects of the new orally active antiestrogen EM-800 with ICI 182 780 and toremifene on estrogen-sensitive parameters in the ovariectomized mouse. Martel, C., Labrie, C., Bélanger, A., Gauthier, S., Mérand, Y., Li, X., Provencher, L., Candas, B., Labrie, F. Endocrinology (1998) [Pubmed]
  25. Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: a population-based case-control study. Pukkala, E., Kyyrönen, P., Sankila, R., Holli, K. Int. J. Cancer (2002) [Pubmed]
  26. Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells. Sarvilinna, N., Eronen, H., Miettinen, S., Vienonen, A., Ylikomi, T. Int. J. Cancer (2006) [Pubmed]
WikiGenes - Universities